OMOP Concept 35807353
Anti-GD2 antibody
ClassificationDrugHemOnc45666Component Class
Maps from
0
Descendants
88
Valid from
27 May 2019
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(4)Roll up to these when you need a wider cohort.
Narrower concepts
(88)Included automatically when you query with descendants.
- 1Dinutuximab beta
- 2COG ANBL0931 post-consolidation
- 2COG ANBL17P1 protocol
- 2Danyelza Injectable Product
- 2dinutuximab 3.5 MG/ML
- 2dinutuximab 3.5 MG/ML [Unituxin]
- 2dinutuximab 4.44 MG/ML
- 2dinutuximab 4.44 MG/ML [Dinutuximab Beta Apeiron]
- 2dinutuximab 4.44 MG/ML [Dinutuximab Beta Eusa]
- 2dinutuximab 4.44 MG/ML [Qarziba]
- 2Dinutuximab beta 4.5 MG/ML
- 2Dinutuximab beta 4.5 MG/ML [Qarziba]
- 2Dinutuximab beta Injectable Solution
- 2Dinutuximab beta Injectable Solution [Qarziba]
- 2Dinutuximab beta Injection
- 2Dinutuximab beta Injection [Qarziba]
- 2dinutuximab Injectable Product
- 2dinutuximab Injectable Solution
- 2dinutuximab Injectable Solution [Qarziba]
- 2dinutuximab Injection
- 2dinutuximab Injection [Dinutuximab Beta Apeiron]
- 2dinutuximab Injection [Unituxin]
- 2dinutuximab Intravenous Solution
- 2dinutuximab Intravenous Solution [Dinutuximab Beta Eusa]
- 2GM-CSF, IL-2, Isotretinoin, Dinutuximab
- 2Irinotecan, Temozolomide, Dinutuximab
- 2Isotretinoin and Dinutuximab beta
- 2naxitamab-gqgk 4 MG/ML
- 2naxitamab-gqgk 4 MG/ML [Danyelza]
- 2naxitamab Injectable Product
- 2naxitamab Injection
- 2naxitamab Injection [Danyelza]
- 2Naxitamab monotherapy
- 2Unituxin Injectable Product
- 310 ML naxitamab-gqgk 4 MG/ML Injection
- 310 ML naxitamab-gqgk 4 MG/ML Injection [Danyelza]
- 31 ML dinutuximab 4.44 MG/ML Injectable Solution
- 34.5 ML dinutuximab 4.44 MG/ML Injectable Solution
- 34.5 ML dinutuximab 4.44 MG/ML Injectable Solution [Qarziba]
- 34.5 ML dinutuximab 4.44 MG/ML Injection
- 34.5 ML dinutuximab 4.44 MG/ML Injection [Dinutuximab Beta Apeiron]
- 34.5 ML dinutuximab 4.44 MG/ML Intravenous Solution [Dinutuximab Beta Eusa]
- 34.5 ML Dinutuximab beta 4.5 MG/ML Injectable Solution
- 34.5 ML Dinutuximab beta 4.5 MG/ML Injectable Solution [Qarziba]
- 34.5 ML Dinutuximab beta 4.5 MG/ML Injection
- 34.5 ML Dinutuximab beta 4.5 MG/ML Injection [Qarziba]
- 35 ML dinutuximab 3.5 MG/ML Injectable Solution
- 35 ML dinutuximab 3.5 MG/ML Injection
- 35 ML dinutuximab 3.5 MG/ML Injection [Unituxin]
- 3dinutuximab 3.5 MG/ML Injectable Solution
Get this concept via the API
Resolve Anti-GD2 antibody - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/35807353?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card